PTC Therapeutics, Inc. (PTCT)

Healthcare · Biotechnology · NASDAQ

PTC Therapeutics, Inc. (PTCT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.51B and a free-cash-flow yield of 7.1%. Over the most recent reported fiscal year, revenue grew 114.5%.

Market cap	$5.51B
Trailing P/E	—
FCF yield	7.1%
Revenue growth (YoY)	+114.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live PTCT data on Nama Insights →